in

Aurobindo Pharma Q3 net profit drops 10% to Rs 846 crore

Aurobindo Pharma on Thursday reported a 10% year-on-year (YoY) decline in net profit to Rs 846 crore in the third quarter ended December 2023, dragged by US sales. despite strong growth momentum in Europe, growth markets and antiretrovirals segment.

The company posted net profit of Rs 940 crore…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Muthoot Microfin Q3 profit slumps 97% to Rs 4 crore on higher provisioning

Swiggy shares crack 7% to 52-week low as Q3 loss widens. Should you buy, sell, or hold?